AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03137121 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: Olanzapine is used as an anti-emetic.
Study NCT03137121 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo is a non-anti-emetic.
Study NCT02670330 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SD-101-6.0 cream
Description: SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.
Study NCT03593863 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Education (PE) programme
Description: The intervention consists of a 10-month (one academic year, September-June) physical activity programme delivered by PE teachers during regular Year-8 PE lessons. The Intervention involves roughly 20 minutes of prescribed activities per week.
Study NCT03452891 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Methylcellulose
Description: Methylcellulose gel will be placed in a deep (6-9 mm) periodontal pocket.
Study NCT03452891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin-Methylcellulose
Description: Simvastatin-Methylcellulose gel will be placed in a deep (6-9 mm) periodontal pocket.
Study NCT02855450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhNGF
Description: Recombinant Human Nerve Growth Factor 180μg/ml (one 35 μl drop equals to 6.30 μg of rhNGF) reconstituted solution three times a day (TID) for 8 weeks of treatment.
Study NCT02855450 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Ophthalmic Placebo solution of the same composition as the test product with the exception of rhNGF reconstituted solution times a day (TID) for 8 weeks of treatment.
Study NCT01562366 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Topaz
Description: Radiofrequency micro debridement with Topaz will be used to treat the gluteal tendons following standard of care procedure
Study NCT01562366 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Iliotibial band release and trochanteric bursectomy
Description: Standard of Care: An iliotibial band release and trochanteric bursectomy will be performed.
Study NCT02118675 — intervention group
Intervention type: OTHER
Intervention: Ultrasound
Description: An ultrasound is a procedure that uses sound waves to create a picture of an organ or soft tissue. This test measures the size of your tissue thicknesses for fat and skeletal muscle. For this procedure, you will be asked to raise your shirt, disrobe from the waist up, or change into a hospital gown and lie flat on your back on an examination table, or sit on a chair, or stand for measuring your leg dimensions. A gel will be spread on the ultrasound probe, and the probe will be applied directly to the skin on your arms, legs, and abdomen. You will feel slight pressure when the probe is applied. The entire procedure will take approximately 30 minutes.
Study NCT04206527 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training of AHSAs on PCC for FP
Description: ASHAs provided with training on FP methods and counseling plus PCC for FP
Study NCT04206527 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced FP training
Description: Participation in an enhanced FP training including PCC
Study NCT02708927 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical evaluation
Description: • Clinical assessment : Expanded Disability Status Scale (EDSS), ambulation test. Medications will be recorded.
Study NCT02708927 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive evaluation
Description: • Neuropsychological, psychological, social and social cognitive evaluation
Study NCT00188266 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatinum combined with infusional fluorouracil (5 FU)
Description: Continuous 5FU via intravenous PICC line + 4 doses of Cisplatin every 2 weeks
Study NCT00780702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Airipiprazole
Description: Participants receive aripiprazole (orally, up to 15 mg/day) plus standard methadone maintenance (daily oral methadone and weekly individual counseling).
Study NCT00780702 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants receive identical capsules containing no active medication plus standard methadone maintenance (daily oral methadone and weekly individual counseling).
Study NCT00731848 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: pomegranate liquid extract
Description: Pomegranate liquid extract, 8 oz per day, for 52 weeks
Study NCT03707964 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Crisis Resource Management Skill Training
Description: Focused crisis resource management training which targets at the cognitive skills needed to monitor and challenge a superior's decision.
Study NCT03707964 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard ACLS Training
Description: Standard didactic interactive session on Advanced Cardiac Life Support (ACLS) principles.
Study NCT01519063 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Naltrexone and memantine first
Description: Naltrexone 50mg memantine 20mg
Study NCT01519063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone and memantine first
Description: Naltrexone 50mg memantine 20mg
Study NCT01519063 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Naltrexone and Placebo first
Description: Naltrexone 50 mg Placebo
Study NCT01519063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone and Placebo first
Description: Naltrexone 50 mg Placebo
Study NCT06123910 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Colostrum bovine
Description: Colostrum bovine supplements, 25 kcal per portion, containing 0.25 g fats, 2.0 g CHO and 3 g protein. Lactose reduced.
Study NCT04578496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afamelanotide
Study NCT06123910 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dairy comercial product. 25 kcal per portion, 1.3 g fats, 1.95 CHO and 1.3 protein. Lactose based.
Study NCT02011867 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cork Electrode
Study NCT02209311 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oral mucosa biopsy
Study NCT02209311 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sinus lift with implantation of tissue engineered construction
Study NCT02209311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dental implant
Study NCT01362946 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reward-Emphasized Treatment
Description: Intensive behavioral treatment delivered in a summer camp setting, with reward components emphasized and punishment components de-emphasized
Study NCT01362946 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Treatment
Description: Intensive behavioral treatment delivered in a summer camp setting, with rewards and punishment equally emphasized.
Study NCT03300752 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BREATHE Intervention
Description: PCPs randomized to BREATHE will receive the tablet which, when the screen is advanced by the PCP, will prompt the PCP through a 7-minute, 4-step brief intervention tailored to respond to the patient's specific beliefs, and shared decision-making discussion of asthma control status and treatment.
Study NCT03300752 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Intervention
Description: PCP will provide discussion of healthy lifestyles.
Study NCT02871193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: ultrasound-guided thoracic paravertebral nerve block (TPVB) with 0.5% ropivacaine 20ml
Study NCT02871193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: ultrasound-guided thoracic paravertebral nerve block (TPVB) with 0.5% ropivacaine 20ml and dexamethasone 5 mg
Study NCT02871193 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: saline
Description: ultrasound-guided thoracic paravertebral nerve block (TPVB) with 0.9% saline 20ml
Study NCT02909842 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Drinking fermented milk
Description: Drinking fermented milk containing Lactobacillus paracasei (IMULUS)
Study NCT02909842 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Acidified placebo milk with similar physical characteristics to the yoghurt drink
Study NCT02909842 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
Description: Intramuscular injection of a single shot of influenza vaccine
Study NCT02909842 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
Description: Intramuscular injection of a single shot of influenza vaccine
Study NCT03309592 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ambrisentan Pill
Description: Will be administered as stated in Arm/Group Descriptions
Study NCT03309592 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tadalafil Pill
Description: Will be administered as stated in Arm/Group Descriptions
Study NCT00878631 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hypertonic saline mixed with dextran
Description: a single dose 250 ml of 7.5% hypertonic saline in 6% dextran 70 is given within 4 hours from the time of the accident
Study NCT00878631 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Normal Saline
Description: 250 ccs of normal saline infused within 4 hours of the accident
Study NCT04433624 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group (B)
Description: Group (B) (n=15): will receive The bilateral ESP blocks were performed by injecting 40 mL of 0.25% bupivacaine (20 mL into each side) into the fascial plane between the deep surface of the erector spinae muscle and the transverse processes of the lumbar vertebrae
Study NCT01374763 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: Prolonged-release oxycodone 10-30 mg twice daily
Study NCT01374763 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prolonged-release oxycodone/naloxone
Description: Prolonged-release oxycodone/naloxone 10-30 mg twice daily
Study NCT01832012 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multimedia
Description: AHA specific BLS refresher video, 7 minutes in length.
Study NCT01832012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimedia
Description: AHA specific BLS refresher video, 7 minutes in length.
Study NCT01832012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hands-on practice
Description: Hands-on BLS CPR practice on a Laerdal BLS manikin.
Study NCT03136133 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active protein drink
Description: Fish protein from cod to be used for man after Heavy excercise to restitute
Study NCT03136133 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Active protein drink
Description: Fish protein from cod to be used for man after Heavy excercise to restitute
Study NCT01689402 — intervention group
Intervention type: DEVICE
Intervention: MRI Scan with the specified sequences below:
Description: Standard sequences: Axial T2, axial DWI, Sagittal T1, T2 flair og axial GRE-sequence.~Susceptibility weighted imaging (SWI)~Chemical Shift Imaging (CSI) multivoxel spectroscopi~Post contrast 3D box reconstruction
Study NCT03769324 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Osmolarity Test
Description: Osmolarity Test
Study NCT03863067 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Epiduroscopy
Description: Using epiduroscopy to treat the ligamentum flavum hypertrophy with Resaflex ,an instrument with Quantum Molecular Resonance for tissue coablation.
Study NCT00518921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capadenoson (BAY 68-4986)
Description: 1mg Capadenoson, double dummy
Study NCT00518921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capadenoson (BAY 68-4986)
Description: 2mg Capadenoson, double dummy
Study NCT00518921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capadenoson (BAY 68-4986)
Description: 4mg Capadenoson, double dummy
Study NCT04916145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAT-008
Description: SAT-008 is a digital device containing several types of activities related to the immune function of adults.
Study NCT00518921 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, double dummy
Study NCT00836277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panitumumab
Description: 9mg/kg IV Day 1 Cycle = 21 days
Study NCT00836277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: 125mg/m2 IV Day 1 and Day 8
Study NCT02787330 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Sessions will not be designed around a specific theme related to childhood cancer and sibling relationships. Activities and games will not have a specific focus. CG sessions will be conducted by facilitators who will receive the standard training for volunteers and will work under the supervision of one of the investigators at each site.
Study NCT02787330 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: The experimental group will be detailed, session by session, in the manual written for this purpose. It addresses on topic per session (respecting each other, medical information about cancer, family relationships, sibling's fears and feelings, relationship between siblings, relationships at school, generating hope.
Study NCT01000727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darapladib 160 mg
Description: Lp-PLA2 inhibitor
Study NCT01000727 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered
Study NCT01000727 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Therapy
Description: Guideline mandated therapy for individual's condition
Study NCT01000727 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Therapy
Description: Guideline mandated therapy for individual's condition
Study NCT01883934 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced clinic-based support/counseling
Description: Additional enhanced support services and educational services provided by embryologists, nurses and physicians in the Frozen Embryo Donation Service will be offered.
Study NCT01883934 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Study NCT03703557 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sorbstar®
Description: Thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry.
Study NCT03703557 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Odour sampling
Description: Analyzed by the dogs of Curie Institute at the training centers
Study NCT02896309 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Study NCT02896309 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Sodium chloride
Study NCT03199833 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RETRAINER-S2
Description: It consists of the execution of different exercises with the affected forearm-hand supported by the RETRAINER-S2 device. The subject is actively involved in the exercises and the system provides two types of support: wrist-fingers motion constraining and FES. The following exercises can be performed: controlled wrist flexion and wrist extension; controlled fingers flexion and extension; repeated grasping of an object; anterior reaching and grasping of an object; moving of objects on a plane or in space.~A subset of exercises is defined based on the patient's capability and the training time is equally shared between the selected exercises. The different training sessions can include different exercises and a different number of repetition for each exercise.
Study NCT03199833 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional therapy
Description: It consists of a combination of different treatment modalities among the following, based on the patient's specific needs:~* Upper limb passive motion~* Arm Cycle ergometer with or without FES~* Neuro Muscular Electrical Stimulation~* Upper limb exercises using augmented or virtual reality environment~* Occupational therapy exercises~* Constraint induced movement therapy~* Upper limb active movement (reaching, grasping, elevation, spatial orientation)~* Repetitive task training~* Mirror therapy~* Writing training~* Chemodenervation Therapy
Study NCT03199833 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional therapy
Description: It consists of a combination of different treatment modalities among the following, based on the patient's specific needs:~* Upper limb passive motion~* Arm Cycle ergometer with or without FES~* Neuro Muscular Electrical Stimulation~* Upper limb exercises using augmented or virtual reality environment~* Occupational therapy exercises~* Constraint induced movement therapy~* Upper limb active movement (reaching, grasping, elevation, spatial orientation)~* Repetitive task training~* Mirror therapy~* Writing training~* Chemodenervation Therapy
Study NCT02175186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALBIS
Study NCT02175186 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03931187 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive progressive muscular relaxation therapy
Description: This therapy combines cognitive psychotherapy and progressive muscular relaxation, intervened 6 times with 1-1.5 hour each time. The whole therapy will last round 28-30 days during IVF-ET.
Study NCT02266615 — intervention group
Intervention type: GENETIC
Intervention: Biobanking of biomaterial for future genetic research.
Study NCT00169117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Songs/posters aimed at behaviour change
Description: This was a behavioural intervention, using songs and posters composed/designed by community members which aimed at behaviour change to increase repair and maintenance of mosquito nets
Study NCT04350736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TD-0903
Description: Study drug to be administered by inhalation
Study NCT04350736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to be administered by inhalation
Study NCT01479959 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Eole 3 ventilator - Resmed
Description: positive end expiratory pressure is added to the ventilation mode and it is activated by a switch under patient's control
Study NCT04703127 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil and Combined Dapoxietine
Description: Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse.
Study NCT04703127 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapoxietine and Combined Lidocaine 5% Spray
Description: Group 2 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.
Study NCT01336166 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: split-virion, non-adjuvanted H1N1 vaccine of 15 μg
Description: 120 adults were assigned to receive 1 dose of 15μg split-virion, non-adjuvanted H1N1 vaccine.
Study NCT01336166 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: split-virion, non-adjuvanted H1N1 vaccine of 30 μg
Description: 120 adults were assigned to receive 1 dose of 30μg split-virion, non-adjuvanted H1N1 vaccine.
Study NCT01336166 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: split-virion, non-adjuvanted H1N1 vaccine of 45 μg
Description: 120 adults were assigned to receive 1 dose of 45μg split-virion, non-adjuvanted H1N1 vaccine.
Study NCT01336166 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo control
Description: 120 adults were assigned to receive 1 dose of placebo.
Study NCT03390712 — intervention group
Intervention type: DRUG
Intervention: Paliperidone Palmitate
Description: Monthly injections
Study NCT03390712 — intervention group
Intervention type: DRUG
Intervention: Risperidal Consta
Description: Bi-weekly injection
Study NCT03390712 — intervention group
Intervention type: DRUG
Intervention: Antipsychotic
Description: Any oral antipsychotic prescribed to be taken on a regular basis prior to the initiation of a long-acting injectable antipsychotic.
Study NCT01420549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.
Description: Tables containing: Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.